Rehman, E. et al. 2022. High Risk of Cardiovascular Events in Patients, Biosynthesis of Aspirin-Resistant Thromboxane And The Risk Of Stroke, Myocardial Infarction Or Death: Biosynthesis of Aspirin-Resistant Thromboxane & Risk of Stroke. Pakistan BioMedical Journal. 5, 6 (Jun. 2022), 213–218. DOI:https://doi.org/10.54393/pbmj.v5i6.583.